PUB041 HGF, VEGFA and ANGPT2 Predict Clinical Benefit from Bevacizumab and Chemotherapy in Patients with Advanced NSCLC (SAKK19/09)Sacha I. Rothschild, Rolf Jaggi, Nathalie Schuster et al.|Journal of Thoracic Oncology|2017Cited by 0